文献速递心血管MR

射血分数保留的心力衰竭中微血管功能障碍的患病率与预后意义

Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
PubMed 文献 · JACC Cardiovasc Imaging · 2022-01-12

前瞻性观察研究纳入101例射血分数保留的心力衰竭(HFpEF)患者和43例对照,用多参数心脏磁共振评估灌注与纤维化。HFpEF患者心肌灌注储备(MPR)低于对照(1.74±0.76 vs 2.22±0.76,P=0.001),微血管功能障碍(MPR<2.0)占70%。MPR经多因素校正后独立预测死亡或心衰住院复合终点。

要点

  • HFpEF患者MPR为1.74±0.76,低于对照的2.22±0.76(P=0.001)。
  • 以MPR<2.0定义微血管功能障碍,HFpEF患者中占70%,对照中占48%(P=0.014)。
  • MPR与弥漫性纤维化无显著线性相关(r=-0.10,P=0.473)。

核心结论

  • 微血管功能障碍在HFpEF患者中高度流行,且是预后的独立预测因子;微血管功能障碍与纤维化缺乏相关性,可能挑战两者存在直接因果联系的论断。

研究设计与样本

  • 前瞻性观察研究,纳入101例HFpEF患者(平均年龄73±9岁,平均射血分数56%±5%)和43例对照(平均年龄73±5岁,平均射血分数58%±5%),行多参数心脏磁共振评估左心室容积、灌注及纤维化(局灶性用晚期钆增强,弥漫性用细胞外容积)。

诊断标准与关键数值

  • 微血管功能障碍定义为心肌灌注储备(MPR)<2.0。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The pathophysiological and clinical significance of microvascular dysfunction (MVD) in patients with heart failure with preserved ejection fraction (HFpEF) remains uncertain.

OBJECTIVES: The aim of this study was to use cardiovascular magnetic resonance to: 1) quantify coronary microvascular function; 2) examine the relationship between perfusion and fibrosis; and 3) evaluate the impact of MVD and fibrosis on long-term clinical outcomes.

METHODS: In a prospective, observational study, patients with HFpEF and control subjects underwent multiparametric cardiovascular magnetic resonance (comprising assessment of left ventricular volumetry, perfusion, and fibrosis [focal by late gadolinium enhancement and diffuse by extracellular volume]). The primary endpoint was the composite of death or hospitalization with heart failure.

RESULTS: One hundred and one patients with HFpEF (mean age 73 ± 9 years, mean ejection fraction 56% ± 5%) and 43 control subjects (mean age 73 ± 5 years, mean ejection fraction 58% ± 5%) were studied. Myocardial perfusion reserve (MPR) was lower in patients with HFpEF versus control subjects (1.74 ± 0.76 vs 2.22 ± 0.76; P = 0.001). MVD (defined as MPR <2.0) was present in 70% of patients with HFpEF (vs 48% of control subjects; P = 0.014). There was no significant linear correlation between MPR and diffuse fibrosis (r = -0.10; P = 0.473) and no difference in MPR between those with and without focal fibrosis (mean difference -0.03; 95% CI: -0.37 to 0.30). In the HFpEF group, during median follow-up of 3.1 years, there were 45 composite events. MPR was independently predictive of clinical outcome following adjustment for clinical, blood, and imaging parameters (1 SD increase: HR: 0.673 [95% CI: 0.463 to 0.978; P = 0.038]; HR: 0.694 [95% CI: 0.491 to 0.982; P = 0.039]; and HR: 0.690 [95% CI: 0.489 to 0.973; P = 0.034], respectively).

CONCLUSIONS: MVD is highly prevalent among patients with HFpEF and is an independent predictor of prognosis. The lack of correlation between MVD and fibrosis may challenge the assertion of a direct causal link between these entities. (Developing Imaging and Plasma Biomarkers in Describing Heart Failure With Preserved Ejection Fraction [DIAMONDHFpEF]; NCT03050593).

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Arnold JR, Kanagala P, Budgeon CA, et al. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction. JACC Cardiovasc Imaging. 2022. PMID: 35033490. doi:10.1016/j.jcmg.2021.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。